On a desert ramp somewhere, a Boeing 787-8 that still smelled of factory sealant was stripped down to its skeleton. Not because it was broken. Because its components were worth more removed than installed.
Thirteen flight hours. That's all this airframe had logged before the part-out decision was made. By any conventional measure, this jet was new. By current market logic, it was more valuable dead.
This isn't a curiosity. It's a signal.
Aircraft economics normally run one direction: jets depreciate over decades, and part-out becomes attractive only when an airframe reaches end-of-life — typically 20-plus years into service. The math flips when component scarcity outpaces whole-aircraft value. That flip, on a nearly new 787, tells you exactly how distorted the spare-parts market has become.
The distortion has a clear origin. Boeing's 787 production effectively stalled from 2021 onward as the FAA held deliveries during quality-control investigations. New components stopped flowing into the MRO ecosystem at normal rates. Simultaneously, the global long-haul fleet — roughly 1,100 787s — came roaring back post-COVID, generating maintenance demand that a compressed supply chain couldn't absorb. No secondhand parts glut exists yet; the 787 fleet is too young and too uniformly in service.
The result: individual components command premiums that, aggregated, exceed what the intact airframe fetches on the open market. Part-out math won.
The downstream consequences extend well beyond one stripped jet. Airlines negotiating AOG recovery now face counterparties who know exactly what a serviceable 787 component is worth. Lease return clauses tied to component condition carry new financial weight. Insurers valuing total-loss settlements are working with a market where the sum of parts genuinely exceeds the whole.
Every 787 still flying is, in a precise financial sense, an aircraft whose organs are worth more than its skeleton.